BioAtla, Inc. ( BCAB) - Key Metrics
Stock symbol BCAB is outdated, potentially delisted? Maybe it is available on other exchange?
BCAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.91 | $0.27 | -$0.25 | -$0.25 |
| 2026Q1 | $0 | -$4.22 | -$3.51 | -$3.51 |
| 2025Q4 | $1.70 | -$8.32 | -$6.73 | -$6.73 |
| 2025Q3 | $0 | -$13.43 | -$8.41 | -$8.41 |
| 2025Q2 | $0 | -$15.99 | -$12.07 | -$12.07 |
BCAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 3.83 |
| 2026Q1 | 0% | -0.48 |
| 2025Q4 | 0% | -0.89 |
| 2025Q3 | 0% | -0.64 |
| 2025Q2 | 0% | -0.31 |
BCAB
Price: $1.74
52 week price:
Earnings Per Share: -25.07 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 285700
Market Capitalization: 5.1 million